Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Strongbridge Biopharma
Strongbridge Biopharma is a biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Sector
Subsector
Location
total rounds
total raised
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for serious diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Cotherix
CoTherix develops biopharmaceutical products for chronic diseases.
Sector
Subsector
Location
total rounds
total raised
Palatin Technologies
Palatin is a biopharmaceutical company developing medicines that target the melanocortin peptide receptor system.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds10
Number of Funding Rounds
Money Raised
Their latest funding was raised on 07.04.2021. Their latest round Post-IPO Equity
Co-Investors
Investors10
Number of lead investors
Number of investors
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Chau Khuong
Chau Q. Khuong joined OrbiMed Advisors in 2003 and is a Partner on the Private Equity team. Chau Khuong has experience in start-up operations and business development at Veritas Medicine, Inc. and in basic science research at the Yale School of Medicine and at Massachusetts General Hospital. He was a summer Associate in the New Ventures technology transfer group at Columbia University. At OrbiMed, Chau Khuong was actively involved investments in Arius Research, Inc. (acquired by Roche in 2008), Peninsula Pharmaceuticals, Inc. (acquired by Johnson & Johnson, Inc., in 2005), Cerexa, Inc. (acquired by Forest Laboratories, Inc., in 2007), Adiana, Inc. (acquired by Cytyc Corporation in 2007), Avanir (NASDAQ: AVNR), and Biodel, Inc. (NASDAQ: BIOD). He currently serves as Director or Observer on the Corporate Boards at Cerapedics, Glaukos Corporation, Intercept Pharma, Sonendo, and Pieris AG. Chau Khuong holds a BS in molecular biology with concentration in biotechnology and an MPH with concentration in infectious diseases, both from Yale University.
current job
count Of Investments
Jennison Associates
Jennison Associates is a wealth management firm that has been fulfilling client investment needs since 1969.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Perceptive Advisors
Perceptive Advisors is a privately owned hedge fund sponsor that finances global public equity markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders2
Jeffrey Harris
Jeffrey Harris, M.D., Ph.D. is a Co-Founder of Otonomy, Inc. Dr. Harris serves as Professor and Chief of the Division of Otolaryngology-Head & Neck Surgery at the University of California, San Diego. A neuro-otologic surgeon who deals with disorders of the ear, hearing and balance, and tumors which affect the skull base. Dr. Harris serves as a Director and Member of Advisory Panel of Otonomy, Inc. He is past President of both the American Otological Society and the Association for Research in Otolarygology and is a Member of the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum. Dr. Harris has an active clinical practice and leads a large research team committed to discovering the causes of deafness and other disorders such as acoustic neuromas, Meniere's disease, autoimmune inner ear disease and the effect of inflammation on inner ear structures. He has published over 150 scientific papers and 4 books including one on Meniere's Disease and his latest on the Head and Neck Manifestations of Systemic Disease. Dr. Harris obtained both his MD and PhD at the University of Pennsylvania and performed his otolaryngology residency training at Harvard. He did advanced fellowship training in Neurotology and Skull Base Surgery at the University of Zurich, and holds two board certifications, in both otolaryngology and neurotology/skull base surgery.
current job
organization founded
Jeffrey Harris
Jay Lichter
Jay Lichter is the Managing Director of Avalon Ventures and he was also the CEO of Sitari Pharmaceuticals. Dr. Lichter received a doctorate and bachelor’s degree in biochemistry from the University of Illinois. He also completed post-doctoral fellowships at Yale University and Du Pont Merck Pharmaceutical Company.
current job
Jay Lichter
Employee Profiles32
Anna Stepanenko
Vice President, Technical Operations
Carla Boren
General Counsel and Chief Human Resources Officer
Adrienne Terrazas
Executive assistant to chief executive officer and chief financial officer and general counsel